News for Healthier Living

Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer's Disease

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

October 2, 2024


October 5 2024

October 4 2024

October 3 2024

October 2 2024

October 1 2024

September 30 2024

September 29 2024

September 28 2024

September 27 2024

September 26 2024

September 25 2024

September 24 2024

September 23 2024

September 22 2024

September 21 2024